Degnan Chris bought URGN

October 8, 2025 · Form 4 insider transaction

Degnan Chris bought 4,483 shares of UROGEN PHARMA LTD, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

4,483

Price

N/A

Total value

N/A

InsiderDegnan Chris

Role—

CompanyUROGEN PHARMA LTD (URGN)

SecurityOrdinary Shares

Transaction codeM — Option exercise

Transaction dateOctober 8, 2025

Filing dateOctober 9, 2025

Shares owned after4,483

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

View the original Form 4 on SEC EDGAR